TY - JOUR
T1 - The formation of an aberrant PAX5 transcript in a patient with mixed phenotype acute leukemia harboring der(9)t(7;9)(q11.2;p13)
AU - Amaki, Jun
AU - Matsushita, Hiromichi
AU - Kitamura, Yuka
AU - Nagao, Ryoko
AU - Murayama, Hiromichi
AU - Kojima, Minoru
AU - Ando, Kiyoshi
N1 - Publisher Copyright:
© 2016 The Authors.
PY - 2016
Y1 - 2016
N2 - We experienced the case of a 56-year-old male with B-lymphoid/myeloid lineage mixed phenotype acute leukemia (MPAL). A cytogenetic analysis of the patient's bone marrow revealed a complex karyotype, including der(9)t(7;9)(q11.2;p13). We identified an aberrant PAX5 transcript, including the exons 1A to 5 and the contiguous intron 5/6 sequence using the 3' rapid amplification of cDNA ends-polymerase chain reaction method, and confirmed their expression in the leukemic cells. Our case suggests that der(9)t(7;9)(q11.2;p13) can cause the truncation of the PAX5 transcript, which is supposed to contribute to the generation of MPAL, in addition to three previously reported types of PAX5 fusion.
AB - We experienced the case of a 56-year-old male with B-lymphoid/myeloid lineage mixed phenotype acute leukemia (MPAL). A cytogenetic analysis of the patient's bone marrow revealed a complex karyotype, including der(9)t(7;9)(q11.2;p13). We identified an aberrant PAX5 transcript, including the exons 1A to 5 and the contiguous intron 5/6 sequence using the 3' rapid amplification of cDNA ends-polymerase chain reaction method, and confirmed their expression in the leukemic cells. Our case suggests that der(9)t(7;9)(q11.2;p13) can cause the truncation of the PAX5 transcript, which is supposed to contribute to the generation of MPAL, in addition to three previously reported types of PAX5 fusion.
KW - Der(9)t(79)(q11.2p13)
KW - MPAL
KW - PAX5
UR - http://www.scopus.com/inward/record.url?scp=84963600693&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84963600693&partnerID=8YFLogxK
U2 - 10.1016/j.lrr.2016.04.001
DO - 10.1016/j.lrr.2016.04.001
M3 - Article
AN - SCOPUS:84963600693
SN - 2213-0489
VL - 5
SP - 14
EP - 17
JO - Leukemia Research Reports
JF - Leukemia Research Reports
ER -